Risk factors for active tuberculosis in human immunodeficiency virus-infected individuals
暂无分享,去创建一个
[1] S. Nie,et al. Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China , 2017, PloS one.
[2] L. Fiebig,et al. Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors , 2014, BMC Infectious Diseases.
[3] C. Ferreyra,et al. Incidence of Tuberculosis in HIV-Infected Patients Before and After Starting Combined Antiretroviral Therapy in 8 Sub-Saharan African HIV Programs , 2011, Journal of acquired immune deficiency syndromes.
[4] D. Westreich,et al. Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies , 2011, Journal of acquired immune deficiency syndromes.
[5] S. Lawn,et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. , 2010, The Lancet. Infectious diseases.
[6] C. Dye,et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. , 2010, International journal of epidemiology.
[7] R. Peto,et al. Smoking, drinking and incident tuberculosis in rural India: population-based case-control study. , 2009, International journal of epidemiology.
[8] L. Jeyaseelan,et al. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile. , 2009, The Indian journal of tuberculosis.
[9] J. Broekmans. Reichman and Hershfield’s tuberculosis: a comprehensive, international approach , 2007 .
[10] M. Bates,et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. , 2007, Archives of internal medicine.
[11] J. Sterne,et al. Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R. Adegbola,et al. Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. , 2005, International journal of epidemiology.
[13] S. Lawn,et al. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control , 2005, AIDS.